Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Acta Neurologica Scandinavica
|
March 21, 2012
Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy
A Bersano, S Lanfranconi, C Valcarenghi, et al.
Current Medicinal Chemistry
|
October 16, 2008
Statins and stroke
A Bersano, E Ballabio, S Lanfranconi, et al.
Clinical Genetics
|
May 29, 2009
Aberrant splicing due to a silent nucleotide change in CCM2 gene in a family with cerebral cavernous malformation
A Tonelli, S Lanfranconi, A Bersano, et al.
Journal of Neurology
|
July 6, 2010
Stenting for the treatment of high-grade intracranial stenoses
S Lanfranconi, A Bersano, V Branca, et al.
Neurology Research International
|
August 9, 2011
Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
S Lanfranconi, S Corti, P Baron, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 22, 2009
New solid modifications of nateglinide
G Bruni, V Berbenni, C Milanese, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 11, 2011
Determination of the nateglinide polymorphic purity through DSC
G Bruni, V Berbenni, C Milanese, et al.
Panminerva Medica
|
March 12, 2013
Genetics of cerebral hemorrhage and microbleeds
S Lanfranconi, G Franco, L Borellini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 3, 2009
Thermodynamic relationships between nateglinide polymorphs
G Bruni, V Berbenni, C Milanese, et al.
Current Medicinal Chemistry
|
June 12, 2012
The genetics of small-vessel disease
A Bersano, S Debette, E R Zanier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Acta Neurologica Scandinavica
|
March 21, 2012
Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy
A Bersano, S Lanfranconi, C Valcarenghi, et al.
Current Medicinal Chemistry
|
October 16, 2008
Statins and stroke
A Bersano, E Ballabio, S Lanfranconi, et al.
Clinical Genetics
|
May 29, 2009
Aberrant splicing due to a silent nucleotide change in CCM2 gene in a family with cerebral cavernous malformation
A Tonelli, S Lanfranconi, A Bersano, et al.
Journal of Neurology
|
July 6, 2010
Stenting for the treatment of high-grade intracranial stenoses
S Lanfranconi, A Bersano, V Branca, et al.
Neurology Research International
|
August 9, 2011
Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
S Lanfranconi, S Corti, P Baron, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 22, 2009
New solid modifications of nateglinide
G Bruni, V Berbenni, C Milanese, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 11, 2011
Determination of the nateglinide polymorphic purity through DSC
G Bruni, V Berbenni, C Milanese, et al.
Panminerva Medica
|
March 12, 2013
Genetics of cerebral hemorrhage and microbleeds
S Lanfranconi, G Franco, L Borellini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 3, 2009
Thermodynamic relationships between nateglinide polymorphs
G Bruni, V Berbenni, C Milanese, et al.
Current Medicinal Chemistry
|
June 12, 2012
The genetics of small-vessel disease
A Bersano, S Debette, E R Zanier, et al.
Page
of 2